AHCO or ABT: Which Is the Better Value Stock Right Now?

Core Viewpoint - Investors in the Medical - Products sector may find AdaptHealth Corp. (AHCO) more attractive than Abbott (ABT) for value investing opportunities [1] Group 1: Zacks Rank and Earnings Outlook - AdaptHealth Corp. has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Abbott has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank focuses on companies with positive earnings estimate revisions, suggesting that AHCO's earnings outlook is improving more significantly than ABT's [3] Group 2: Valuation Metrics - AHCO has a forward P/E ratio of 8.26, significantly lower than ABT's forward P/E of 25.36 [5] - AHCO's PEG ratio is 1.02, while ABT's PEG ratio is 2.43, indicating that AHCO is expected to grow earnings at a more favorable rate relative to its price [5] - AHCO's P/B ratio is 0.79, compared to ABT's P/B of 5.65, further highlighting AHCO's undervaluation [6] Group 3: Overall Value Assessment - Based on various valuation metrics, AHCO holds a Value grade of A, while ABT has a Value grade of C, suggesting that AHCO is the superior value option at this time [6]